Resistance to β-lactam antibiotics mediated by alterations of PBPs has been reported in some gram-negative bacteria.
These enzymes are inserted in the cytoplasmic membrane only at their amino termini, and water-soluble forms have been obtained that should be suitable for crystallization and X-ray analysis. The high-molecular-weight PBPs of Escherichia coli are believed to possess an amino-terminal peptidoglycan transglycosylase domain and a carboxy-terminal penicillin-sensitive transpeptidase domain. This view is strongly supported by the recent finding of a similarity in the three-dimensional structures of a low-molecular-weight PBP and class A β-lactamases. The availability of the amino acid sequences of several low-molecular-weight PBPs, high-molecular-weight PBPs, and active-site serine β-lactamases has provided evidence that these groups of enzymes have a common, but distant, evolutionary origin. As a transporter candidate, FtsW is probably the last protein to interact with lipid II before its polymerization by the glycosyltransferase.
School of Life Sciences, University of Warwick, Coventry, CV47AL, UK.Β-Lactam antibiotics exert their antibacterial effects by inactivating the high-molecular-weight penicillin-binding proteins (PBPs) that are responsible for the final stages of peptidoglycan biosynthesis. FtsW, PBP3 and PBP1b form a ternary complex in vitro. Structures of PBP3 in complexes with azlocillin and cefoperazone, which are in clinical use for the treatment of pseudomonad infections, have been determined to 2.0 resolution. Here we focus on structural based interpretations of amino acid alterations associated with the emergence of resistance within clinical isolates and include new PBP3 structures along with new, and improved, PBP-β-lactam co-structures. Penicillin-binding protein 3 (PBP3) from Pseudomonas aeruginosa is the molecular target of -lactam-based antibiotics. Analysis of the translated sequence of the pbpC gene encoding this PBP3x revealed that 41 and 48 of its amino acids were identical. Resistance is predominantly mediated by reducing the target drug concentration via β-lactamases however, naturally transformable bacteria have also acquired target-mediated resistance by inter-species recombination. A homolog of Pseudomonas aeruginosa penicillin-binding protein 3 (PBP3), named PBP3x in this study, was identified by using degenerate primers based on conserved amino acid motifs in the high-molecular-weight PBPs. Named after their ability to bind penicillin, rather than their catalytic activity, these key targets are called penicillin-binding proteins (PBPs). cereus ts-4 pbp3 gene consisted of an open reading frame of 1,986 bp encoding 662 amino acid residues with a. The periplasmic/extra-cytoplasmic targets of penicillin are a family of enzymes with a highly conserved catalytic activity involved in the final stage of bacterial cell wall (peptidoglycan) biosynthesis. Isolates showing this type of resistance are known as -lactamase negative ampicillin-resistant (BLNAR) or rPBP3, and, unlike in -lactamase-producing strains, their reduced susceptibility to aminopenicillins is not affected by -lactamase inhibitors. Even with the emergence of antibiotic resistance, penicillin and the wider family of β-lactams have remained the single most important family of antibiotics. It is a structural alteration of the penicillin-binding protein (PBP3) encoded by the ftsI gene.
0 kommentar(er)
